Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.43 |
| ▸ | FDPS | P14324 | 4/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10775700 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL10771326 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL10774678 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL1904191 | 0.97 | DNM1 (0.48) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL5903021 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL10775752 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL9543091 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL10773668 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL10945828 | 0.97 | OPRM1 (0.46) | OPRM1TSHRTHRBLMNADNM1 | |
| SCHEMBL10774657 | 0.97 | TSHR (0.50) | OPRM1TSHRTHRBLMNADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110275392-B | Light-converting resin composition, light-converting laminate substrate, and image display device | 东友精细化工有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-110297391-B | Light conversion resin composition, light conversion laminated substrate, and image display device | 东友精细化工有限公司 | 2022-12-20 | — | — | CN | claimed |
| EP-3340283-B1 | WAFER WASHING METHOD, AND LIQUID CHEMICAL USED IN SAME | CENTRAL GLASS CO LTD (JP) | 2020-05-20 | — | — | EP | claimed |
| EP-2985279-B1 | Heterocyclic compounds with working memory enhancing activity | RED BULL GMBH (AT) | 2017-08-02 | — | — | EP | claimed |
| US-20170174642-A1 | HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY | COGMOTIV FLEXCO (AT) | 2017-06-22 | — | — | US | claimed |
| EP-2886539-B1 | 10-Thiosubstituted pentahydroxyanthracene derivatives, a method of their preparation and intermediate compounds | CENTRUM BADAN MOLEKULARNYCH I MAKROMOLEKULARNYCH POLSKIEJ AKADEMII NAUK (PL) | 2017-02-01 | — | — | EP | claimed |
| EP-2985279-A1 | Heterocyclic compounds with working memory enhancing activity | Red Bull GmbH (AT) | 2016-02-17 | — | — | EP | claimed |
| EP-2886539-A1 | 10-Thiosubstituted pentahydroxyanthracene derivatives, a method of their preparation and intermediate compounds | Centrum Badan Molekularnych I Makromolekularnych Polskiej Akademii Nauk (PL) | 2015-06-24 | — | — | EP | claimed |
| CN-111406233-B | Photosensitive resin composition, dry film resist and cured product thereof | 日本化药株式会社 | 2023-12-26 | — | — | CN | disclosed |
| CN-110275392-B | Light-converting resin composition, light-converting laminate substrate, and image display device | 东友精细化工有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-109563128-B | Malignant tumor targeting peptide | 国立研究开发法人产业技术总合研究所 | 2023-02-28 | — | — | CN | disclosed |
| CN-110297391-B | Light conversion resin composition, light conversion laminated substrate, and image display device | 东友精细化工有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-111320898-B | Light conversion ink composition, light conversion pixel, color filter, and image display device | 东友精细化工有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-110305451-B | Light conversion resin composition, light conversion laminated substrate, and image display device | 东友精细化工有限公司 | 2021-10-22 | — | — | CN | disclosed |
| WO-1991018905-A1 | RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY | SANKYO COMPANY LIMITED (JP) | 1991-12-12 | — | — | WO | disclosed |
| US-4702822-A | ORGANIC SULFIDE WITH ALKYL THIOCARBONATE, THIONACARBAMATEA, OR THIOPHOSPHATE | THE DOW CHEMICAL COMPANY (US) | 1987-10-27 | — | — | US | disclosed |
| US-4676890-A | MIXTURE OF THIOALKYL AMINE AND HYDROCARBYL SULFIDES; SULFIDE ORES; PREFERENTIAL | THE DOW CHEMICAL COMPANY (US) | 1987-06-30 | — | — | US | disclosed |
| WO-1987003222-A1 | COLLECTOR COMPOSITIONS FOR THE FROTH FLOTATION OF MINERAL VALUES | THE DOW CHEMICAL COMPANY (US) | 1987-06-04 | — | — | WO | disclosed |
| WO-1987000451-A1 | NOVEL COLLECTOR COMPOSITION FOR FROTH FLOTATION | THE DOW CHEMICAL COMPANY (US) | 1987-01-29 | — | — | WO | disclosed |
| WO-1986006983-A1 | NOVEL COLLECTORS FOR THE SELECTIVE FROTH FLOTATION OF SULFIDE MINERALS | THE DOW CHEMICAL COMPANY (US) | 1986-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174642-A1 | HETEROCYCLIC COMPOUNDS WITH WORKING MEMORY ENHANCING ACTIVITY | TAAR1, ACHE, RIF1 | OPRM1 1858/4885TSHR 796/4885THRB 984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.